<DOC>
	<DOCNO>NCT00440141</DOCNO>
	<brief_summary>Patients glaucoma ocular hypertension currently treat latanoprost 0.005 % , need additional IOP lower randomize receive either brimonidine 0.1 % brinzolamide 1 % three-times daily adjunctive therapy latanoprost 0.005 %</brief_summary>
	<brief_title>Brimonidine 0.1 % Versus Brinzolamide 1 % Adjunctive Therapy Latanoprost 0.005 %</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Glaucoma ocular hypertension eye Currently treat latanoprost 0.005 % QD IOP great equal 18mm Hg latanoprost 0.005 % Bestcorrected VA 20/200 good eye Visual field within 6 month study entry Secondary glaucoma Active intraocular inflammation macular edema Intraocular surgery laser surgery within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>